Planned Parenthood has won a partial victory in a legal fight with President Donald Trump’s administration over its efforts ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

“I commend Senegal for freeing its population from this disease”, said Dr Tedros Adhanom Ghebreyesus, WHO director-general.“This milestone is yet another sign of the remarkable progress being made ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...

Follow the latest on Trump’s tariffs; Donald Trump has threatened to introduce tariffs of up to 200pc on pharmaceutical ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and why it is a Buy.

Pfizer Inc. (NYSE:PFE) is navigating a period of strategic upheaval and legal scrutiny as it ends its clinical collaboration with Acepodia and faces mounting lawsuits over its contraceptive, Depo ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an mRNA bird ...

Pfizer is in-licensing a bispecific antibody drug for cancer that China-based 3SBio designed to block the proteins PD-1 and VEGF. The deal puts the pharmaceutical giant in a growing group of ...

Kansas Attorney General Kris Kobach sued Pfizer over its marketing of the COVID-19 vaccine. A federal judge sent the case back to state court.

The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until after the 2020 election ...